NLC is a pioneering healthtech venture builder based in Europe, dedicated to transforming innovative scientific breakthroughs into scalable and investable companies. With a track record of creating over 100 ventures, NLC identifies breakthrough innovations in the health sector and assembles expert teams to support each venture from the lab to market. The company provides hands-on operational guidance, fundraising support, and access to dedicated capital, enabling founders to advance their projects effectively. NLC is currently collaborating with a new biotech startup focused on developing a groundbreaking treatment targeting cancer stem cells, aiming to revolutionize cancer care.